Continuous infusion of recombinant activated factor VII for bleeding control after lobectomy in a patient with inherited factor VII deficiency

被引：0
|
作者：
Naoko Miyata
Mitsuhiro Isaka
Hideaki Kojima
Tomohiro Maniwa
Shoji Takahashi
Osamu Takamiya
Yasuhisa Ohde
机构：
[1] Shizuoka Cancer Center,Division of Thoracic Surgery
[2] Nagahama Institute of Bio-Science and Technology,Department of Bioscience, Faculty of Bioscience
来源：
General Thoracic and Cardiovascular Surgery | 2016年 / 64卷
关键词：
Inherited factor VII deficiency; Continuous infusion; Recombinant activated factor VII; Lobectomy;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
Inherited factor VII (FVII) deficiency is a rare recessive inherited coagulation disorder with limited available information, especially in patients undergoing major thoracic surgery. In addition, an optimal management strategy for the disease has not been defined. We herein report a case involving a 61-year-old man with asymptomatic FVII deficiency who underwent a right middle and lower lobectomy to treat lung cancer. To the best of our knowledge, the present report is the first to describe the use of recombinant activated FVII continuous infusion for bleeding control after a major thoracic surgery in a patient with inherited FVII deficiency.
引用
收藏
页码：177 / 180
页数：3
相关论文
共 50 条
  • [31] A Comparison Between Recombinant Activated Factor VII (Aryoseven) and Novoseven in Patients With Congenital Factor VII Deficiency
    Faranoush, M.
    Abolghasemi, Hassan
    Toogeh, Gh.
    Karimi, M.
    Eshghi, P.
    Managhchi, M.
    Hoorfar, H.
    Dehdezi, B. Keikhaei
    Mehrvar, A.
    Khoeiny, B.
    Kamyar, K.
    Heshmat, R.
    Baghaeipour, M. R.
    Mirbehbahani, N. B.
    Fayazfar, R.
    Ahmadinejad, M.
    Naderi, M.
    [J]. CLINICAL AND APPLIED THROMBOSIS-HEMOSTASIS, 2015, 21 (08) : 724 - 728
  • [32] Newly diagnosed congenital factor VII deficiency and utilization of recombinant activated factor VII (NovoSeven (R))
    Bartosh, Nicole S.
    Tomlin, Tara
    Cable, Christian
    Halka, Kathleen
    [J]. CLINICAL PHARMACOLOGY-ADVANCES AND APPLICATIONS, 2013, 5 : 53 - 58
  • [33] Recombinant activated coagulation factor VII and bleeding trauma patients
    Rizoli, Sandro B.
    Nascimento, Bartolomeu, Jr.
    Osman, Fahima
    Netto, Fernando Spencer
    Kiss, Alex
    Callum, Jeannie
    Brenneman, Frederick D.
    Tremblay, Lorraine
    Tien, Homer C.
    [J]. JOURNAL OF TRAUMA-INJURY INFECTION AND CRITICAL CARE, 2006, 61 (06): : 1419 - 1425
  • [34] Variation in the use of recombinant activated factor VII in critical bleeding
    Willis, C. D.
    Cameron, P. A.
    Phillips, L.
    [J]. INTERNAL MEDICINE JOURNAL, 2010, 40 (07) : 486 - 493
  • [35] Experience with continuous infusion of recombinant activated factor VII in the Asia-Pacific region
    McPherson, J
    Sutcharitchan, P
    Lloyd, J
    Street, A
    Jorgensen, LN
    Yang, SI
    [J]. BLOOD COAGULATION & FIBRINOLYSIS, 2000, 11 : S31 - S34
  • [36] Activated recombinant factor VII in management of bleeding in patients with thrombocytopenia
    E Shulutko
    V Gorodetsky
    [J]. Critical Care, 10 (Suppl 1):
  • [37] Management of severe sphincterotomy bleeding with recombinant activated factor VII
    Garrido-Serrano, Antonio
    [J]. GASTROINTESTINAL ENDOSCOPY, 2012, 76 (04) : 925 - 926
  • [38] Recombinant activated factor VII in the management of massive obstetric bleeding
    Palomino, MAP
    Chaparro, MJS
    De Elvira, MJZR
    Curiel, EB
    [J]. BLOOD COAGULATION & FIBRINOLYSIS, 2006, 17 (03) : 226 - 227
  • [39] Clinical effectiveness of recombinant activated factor VII in bleeding disorders
    el Fegoun, Soraya Benchikh
    Cooper, David L.
    Seremetis, Stephanie
    Negrier, Claude
    Neufeld, Ellis J.
    [J]. HAEMOPHILIA, 2018, 24 : 60 - 61
  • [40] Recombinant activated factor VII for uncontrolled bleeding postcardiac surgery
    Habib, Aly Makram
    Mousa, Ahmed Yehia
    Al-Halees, Zohair
    [J]. JOURNAL OF THE SAUDI HEART ASSOCIATION, 2016, 28 (04) : 222 - 231
12345